Woburn, Massachusetts-based Organix has a team of 45 people, all of whom will be joining Symeres, according to Thomas. “It’s all about the people, as is often the case," he said.

Organix In a bid to cash in on the growing market for RNA-based therapies and vaccines, Dutch contract research firm Symeres has acquired Woburn’s Organix for undisclosed terms.